- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Doximity is a health information services business based in the US. Doximity shares (DOCS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $54.20 – an increase of 1.23% over the previous week. Doximity employs 827 staff and has a trailing 12-month revenue of around $516.8 million.
Our top picks for where to buy Doximity stock
- Trade $0 commission stocks, ETFs, and options with as little as $1
- After-hours trading available
- Earn 4.5% interest on uninvested cash with Gold
- 24/7 customer support
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Complimentary access to a financial planner
How to buy Doximity stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DOCS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Doximity stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Doximity stock price (NYSE: DOCS)
Use our graph to track the performance of DOCS stocks over time.Doximity shares at a glance
Latest market close | $54.20 |
---|---|
52-week range | $22.96 - $61.75 |
50-day moving average | $45.10 |
200-day moving average | $32.90 |
Wall St. target price | $56.75 |
PE ratio | 61.3678 |
Dividend yield | N/A |
Earnings per share (TTM) | $0.87 |
Is it a good time to buy Doximity stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Doximity price performance over time
Historical closes compared with the close of $53 from 2024-11-29
1 week (2024-11-26) | -1.01% |
---|---|
1 month (2024-11-04) | 26.73% |
3 months (2024-09-03) | 47.63% |
6 months (2024-06-03) | 91.75% |
1 year (2023-12-01) | 117.66% |
---|---|
2 years (2022-12-02) | 49.42% |
3 years (2021-12-03) | 59.86 |
5 years (2019-11-30) | N/A |
Is Doximity stock undervalued or overvalued?
Valuing Doximity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Doximity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Doximity's P/E ratio
Doximity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Doximity shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Doximity's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.
- Nextgen Healthcare (NXGN.US): 0.00
- Cerner (CERN.US): 48.06
- Veradigm (MDRX.US): 11.12
Doximity's PEG ratio
Doximity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4191. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Doximity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Doximity's PEG ratio in relation to those of similar companies.
- Nextgen Healthcare (NXGN.US): 2.56
- Cerner (CERN.US): 5.66
- Veradigm (MDRX.US): 2.42
Doximity's EBITDA
Doximity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $207.9 million.
The EBITDA is a measure of a Doximity's overall financial performance and is widely used to measure a its profitability.
To put Doximity's EBITDA into context you can compare it against that of similar companies.
- Nextgen Healthcare (NXGN.US): USD$54.5 million
- Cerner (CERN.US): USD$1.6 billion
- Veradigm (MDRX.US): USD$115.4 million
Doximity financials
Revenue TTM | $516.8 million |
---|---|
Operating margin TTM | 40.68% |
Gross profit TTM | $365.6 million |
Return on assets TTM | 11.83% |
Return on equity TTM | 19% |
Profit margin | 33.69% |
Book value | $5.15 |
Market Capitalization | $10 billion |
TTM: trailing 12 months
Doximity share dividends
We're not expecting Doximity to pay a dividend over the next 12 months.
You may also wish to consider:
- Cerner (CERN.US) (1.14% forward annual dividend yield)
Doximity share price volatility
Over the last 12 months, Doximity's shares have ranged in value from as little as $22.96 up to $61.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Doximity's is 1.296. This would suggest that Doximity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Doximity's beta into context you can compare it against those of similar companies.
- Nextgen Healthcare (NXGN.US): 0.77
- Cerner (CERN.US): 0.7613
- Veradigm (MDRX.US): 0.604
Doximity overview
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.
Frequently asked questions
nullWhat percentage of Doximity is owned by insiders or institutions?
Currently 2.717% of Doximity shares are held by insiders and 92.143% by institutions. How many people work for Doximity?
Latest data suggests 827 work at Doximity. When does the fiscal year end for Doximity?
Doximity's fiscal year ends in March. Where is Doximity based?
Doximity's address is: 500 3rd Street, San Francisco, CA, United States, 94107 What is Doximity's ISIN number?
Doximity's international securities identification number is: US26622P1075
More guides on Finder
-
Best Paper Trading Apps to Practice Trading With Fake Money in 2024
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
-
5 Best International Stock Brokers to Invest in Foreign Assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
9 Best Robo-Advisors for Automatic Investing
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Betterment alternatives
5 Betterment robo-advisor alternatives to consider when building your portfolio.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to gift stock
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
Acorns review 2024
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.
Ask a question